BR0309340A - Materiais, sua preparação e uso - Google Patents

Materiais, sua preparação e uso

Info

Publication number
BR0309340A
BR0309340A BR0309340-9A BR0309340A BR0309340A BR 0309340 A BR0309340 A BR 0309340A BR 0309340 A BR0309340 A BR 0309340A BR 0309340 A BR0309340 A BR 0309340A
Authority
BR
Brazil
Prior art keywords
component
components
precipitate
amphiphilic
precipitates
Prior art date
Application number
BR0309340-9A
Other languages
English (en)
Inventor
Lajos Szente
Jozsef Szejtli
Gyeorgy Lajos Kis
Christian Schoch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0309340A publication Critical patent/BR0309340A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"MATERIAIS, SUA PREPARAçãO E USO". A presente invenção refere-se a novos materiais, particularmente biomateriais, na forma de um precipitado, compreendendo pelo menos um componente polimérico aniónico que é, como tal, solúvel em água e um componente anfifílico do tipo amónio, precipitado o qual é obtenível por meio de um processo o qual inclui as seguintes etapas de processo: 1. contato do componente polimérico aniónico e um componente de ciclodextrina em um meio aquoso e 2. adição, à mistura obtida na etapa 1, do componente anfifílico do tipo amónio; em que os referidos componentes estão presentes em quantidades eficazes para formar o referido precipitado e, de preferência, precipitados correspondentes compreendendo adicionalmente o referido componente de ciclodextrina. Ambos os tipos de precipitado podem, opcionalmente, compreender um ou mais de outros componentes. Os precipitados são particularmente úteis como formulações depósito de liberação controlada adequadas para distribuição duradoura dos referidos outros componentes. Os outros componentes incorporados nos precipitados podem ser compostos farmacêuticos, pesticidas, agroquímicos, colorantes, produtos diagnósticos, enzimas, gêneros alimentícios, etc.
BR0309340-9A 2002-04-19 2003-04-17 Materiais, sua preparação e uso BR0309340A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02008809 2002-04-19
PCT/EP2003/004076 WO2003089008A1 (en) 2002-04-19 2003-04-17 Novel biomaterials, their preparation and use

Publications (1)

Publication Number Publication Date
BR0309340A true BR0309340A (pt) 2005-03-08

Family

ID=29225593

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309340-9A BR0309340A (pt) 2002-04-19 2003-04-17 Materiais, sua preparação e uso

Country Status (19)

Country Link
US (3) US20050163853A1 (pt)
EP (1) EP1499361B1 (pt)
JP (1) JP4648632B2 (pt)
KR (1) KR101121675B1 (pt)
CN (1) CN1646171B (pt)
AU (1) AU2003224099B2 (pt)
BR (1) BR0309340A (pt)
CA (1) CA2484100C (pt)
CO (1) CO5611168A2 (pt)
ES (1) ES2392964T3 (pt)
IL (1) IL164627A (pt)
MX (1) MXPA04010325A (pt)
NO (1) NO20044979L (pt)
NZ (1) NZ535810A (pt)
PL (1) PL215579B1 (pt)
PT (1) PT1499361E (pt)
RU (1) RU2321597C2 (pt)
WO (1) WO2003089008A1 (pt)
ZA (1) ZA200407794B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
CN100548271C (zh) * 2004-01-20 2009-10-14 阿勒根公司 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
WO2006011044A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Amorphous cyclodextrin compositions
US20060089590A1 (en) * 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
ES2383303T3 (es) 2005-11-10 2012-06-20 Chemi S.P.A. Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina
JP2009186445A (ja) * 2008-02-08 2009-08-20 Arkray Inc キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬
EP2060912B1 (en) * 2006-09-04 2014-10-01 National Institute of Advanced Industrial Science and Technology Method for analysis of sample by capillary electrophoresis
US20100155242A1 (en) * 2006-09-04 2010-06-24 Arkray, Inc. Method of Analyzing a Sample by Capillary Electrophoresis
EP2060913B1 (en) * 2006-09-04 2016-11-02 National Institute of Advanced Industrial Science and Technology Method for analysis of sample by capillary electrophoresis
CA2753641C (en) 2009-02-25 2014-09-16 Supratek Pharma, Inc. Bendamustine cyclopolysaccharide compositions
US20110015245A1 (en) * 2009-07-20 2011-01-20 Valery Alakhov Bendamustine amphiphilic cationic compositions
US8389558B2 (en) * 2009-07-20 2013-03-05 Supratek Pharma Inc. Bendamustine amphiphilic anionic compositions
JP2013521796A (ja) 2010-03-13 2013-06-13 イーストポンド・ラボラトリーズ・リミテッド 脂肪結合性組成物
US8383663B2 (en) 2010-07-19 2013-02-26 Supratek Pharma Inc. Bendamustine anionic-catioinic cyclopolysaccharide compositions
AU2010366535A1 (en) 2010-12-31 2013-07-11 Eastpond Laboratories Limited Cellular hydration compositions containing cyclodextrins
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
BR112013018933A2 (pt) * 2011-02-10 2016-09-13 Unilever Nv composições antiviral, antisséptica líquida, e sólida para a lavagem pessoal, de limpeza sólida e líquida da superfície rígida, antimicrobiana, higienizadora de mãos, método de desinfecção de uma superfície e utilização de uma composição
CN104185661B (zh) 2012-01-18 2016-08-17 苏尔莫迪克斯公司 低微粒的润滑性医疗装置涂层
EP2928500B1 (en) * 2012-12-04 2019-03-06 Phosphorex Inc. Microparticles and nanoparticles having negative surface charges
JP6449249B2 (ja) * 2013-05-17 2019-01-09 マーケット ユニバーシティー イオン性液体組成物から形成される構造多糖および大環状化合物を含有する複合材料
JP5673756B2 (ja) * 2013-08-20 2015-02-18 東洋紡株式会社 医療用材料
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
WO2016206738A1 (en) 2015-06-24 2016-12-29 Kao Germany Gmbh Hair treatment process
US10342898B2 (en) * 2015-12-29 2019-07-09 Surmodics, Inc. Lubricious coatings with surface salt groups
US11174447B2 (en) 2015-12-29 2021-11-16 Surmodics, Inc. Lubricious coatings with surface salt groups
EP3528856B1 (en) 2016-10-18 2023-07-12 Marquette University Composite materials containing structural polymers and photoreactive nitric oxide releasing agents and uses thereof for wound dressings
WO2020257316A1 (en) 2019-06-17 2020-12-24 Marquette University Materials based on natural pollen grains and uses thereof
WO2021205237A1 (en) 2020-04-06 2021-10-14 Eastpond Laboratories Limited Compositions for promoting cellular hydration
CN114344557A (zh) * 2022-01-10 2022-04-15 山东万容生物科技有限公司 一种含环糊精的水胶体敷料及其制备方法
WO2023212740A1 (en) * 2022-04-29 2023-11-02 Drexel University Surfactant-impregnated mof-coated fabric for antimicrobial applications

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (pt) * 1964-10-14 1966-01-31
JPS61251616A (ja) * 1985-04-30 1986-11-08 Agency Of Ind Science & Technol 溶質の放出量の制御方法
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
JPH03234770A (ja) * 1990-02-09 1991-10-18 Nippon Shokubai Kagaku Kogyo Co Ltd 電気刺激応答性ゲルの製法
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
JPH08134134A (ja) * 1994-11-09 1996-05-28 Nippon Shokubai Co Ltd 粒子状含水ゲル重合体の乾燥方法
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH0995413A (ja) * 1995-09-29 1997-04-08 Shiseido Co Ltd 皮膚外用剤
RU2173172C2 (ru) * 1997-05-05 2001-09-10 Сайдекс Инк. Твердые фармацевтические препараты, содержащие физическую смесь сульфоалкилового эфира циклодекстрина и терапевтического агента
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000004916A1 (en) * 1998-07-23 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Encapsulation of water soluble peptides
WO2000041541A2 (en) * 1999-01-12 2000-07-20 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
JP2001318350A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ用溶液
AU2001261403B2 (en) * 2000-05-15 2006-04-06 The Procter & Gamble Company Compositions comprising cyclodextrin
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds

Also Published As

Publication number Publication date
EP1499361A1 (en) 2005-01-26
US20050163853A1 (en) 2005-07-28
KR20040103968A (ko) 2004-12-09
IL164627A0 (en) 2005-12-18
RU2321597C2 (ru) 2008-04-10
HK1073070A1 (en) 2005-09-23
JP4648632B2 (ja) 2011-03-09
PL371595A1 (en) 2005-06-27
CO5611168A2 (es) 2006-02-28
IL164627A (en) 2009-11-18
CA2484100A1 (en) 2003-10-30
CA2484100C (en) 2012-01-03
NZ535810A (en) 2007-11-30
CN1646171B (zh) 2010-05-26
PT1499361E (pt) 2012-11-22
PL215579B1 (pl) 2013-12-31
NO20044979L (no) 2004-11-16
WO2003089008A1 (en) 2003-10-30
US20120040901A1 (en) 2012-02-16
AU2003224099A1 (en) 2003-11-03
CN1646171A (zh) 2005-07-27
US20080299166A1 (en) 2008-12-04
EP1499361B1 (en) 2012-08-08
KR101121675B1 (ko) 2012-03-13
JP2005529879A (ja) 2005-10-06
MXPA04010325A (es) 2005-06-08
ES2392964T3 (es) 2012-12-17
ZA200407794B (en) 2006-02-22
RU2004133887A (ru) 2005-10-20
AU2003224099B2 (en) 2006-11-09

Similar Documents

Publication Publication Date Title
BR0103844A (pt) Sistema de aditivo polimérico múltiplo, processo para produzir o mesmo, composição polimérica, e, processo para produzir a mesma
BRPI0408925A (pt) veìculos de fase simples não-aquosos e formulações utilizando tais veìculos
BRPI0410037B8 (pt) inibidores de fosfatidilinositol 3-cinase, sua composição farmacêutica, e seu uso
BR0212008A (pt) Uso de um composto ou de um sal, solvato ou pró-medicamento deste, composição farmacêutica, composto ou um sal, solvato ou pró-medicamento deste, e, processo para a preparação deste
BR9815570A (pt) Composto, processo de preparação dos compostos, utilização de pelo menos um composto, composição cosmética ou farmacêutica e utilização de pelos menos um polìmero
BR0315767A (pt) Composição imunogência, método para fabricar uma vacina, kit, vacina, recipiente com uma superfìcie interna repelente à água, e, método para preservar uma composição que compreende ipv e um agente estabilizador
NO20044979L (no) Nye biomaterialer, deres fremstilling og anvendelse
BRPI0409227A (pt) composto, composição farmacêutica, uso de um composto, intermediário, e, processo para a preparação de um composto
BR0305916A (pt) Dispersão, composição cosmética ou farmacêutica e processo para tratamento cosmético
BR0111667A (pt) Novos compostos
BR0309546A (pt) Composto, composição farmacêutica que compreende o mesmo, processo para a sua preparação e utilização e método para tratamento profilático ou terapêutico de diabetes do tipo ii
BR9914932A (pt) Processo para a manufatura de uma composição de isotretinoìna, composição de isotretinoìna micronizada, forma de dosagem unitária para administração enteral e composição farmacêutica na forma de dosagem unitária
BR0214553A (pt) Compostos, processo de preparação, em fase lìquida, dos compostos, e, composições farmacêuticas
BRPI0416032A (pt) excipientes em veìculos de distribuição de fármacos
BR0116691A (pt) Produto antitranspirante, métodos cosméticos para atingir antitranspiração e/ou benefìcio desodorante e método para a fabricação de uma composição antitranspirante
BR0208973A (pt) Composição alimentìcia de animal de estimação contendo agente de formação de gel semi-refinado
WO2004010941A3 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
BR0204115A (pt) Utilização de um copolìmero anfìfilo, processo de preparação de uma dispersão de um composto orgânico insolúvel, dispersão e composição cosmética de uso tópico
BRPI0411500A (pt) pesticida para aplicar um aniquilamento de modo de ação fìsica, composição hidrocoloidal, método de aniquilamento de pestes em plantas pelo modo fìsico de operação e processo para a preparação de um pesticida
BR0208468A (pt) Camsilato de amlodipina e processo para sua preparação
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
MX9401211A (es) Composicion y procedimiento para combatir la aglomeracion de abonos.
BR0113473A (pt) Dispersão aquosa e seu uso na preparação de materiais de revestimento, adesivos e compostos de selagem actìnicos e curáveis com calor.
BR0008297A (pt) Uso de 4,6-o-(benzilideno-d1) -d-glucopiranose, 4,6-o-benzilideno-l-glucopiranose, e/ou 4,6-o-(benzilideno-d1) -l-glucopiranose, ou um sal farmacêutico aceitável dos mesmos, derivado de benzaldeìdo composição farmacêutica, e, processo para a fabricação da mesma
BR0016678A (pt) Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.